| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/2009 | CN101467983A Menatetrenone soft capsule and preparation method thereof |
| 07/01/2009 | CN100506999C Optimized expression of HPV 31 L1 in yeast |
| 07/01/2009 | CN100506870C Facially amphiphilic polymers as anti-infective agents |
| 07/01/2009 | CN100506835C Segment of alginic acid oligosaccharide, preparation method and application |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506825C Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors |
| 07/01/2009 | CN100506821C Tetrahydropyridoethers |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506807C Amide derivatives as GK activators |
| 07/01/2009 | CN100506803C Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 07/01/2009 | CN100506802C Formyl peptide-like acceptor-1 regulator and its Preparation and use |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506797C Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 07/01/2009 | CN100506795C Indene ketone diindyl class compound, preparation method and medical use thereof |
| 07/01/2009 | CN100506793C Vitamin D* lactam derivative |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506790C Modafinil polymorphic forms |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506785C Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506769C Preparation and use of compounds i.e., 1,3-dihydroxy-5-alkyl benzene as inhibitor of protein-tyrosine-phosphatase 1B |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506235C Freeze-dried preparation for treating cerebral vascular disease |
| 07/01/2009 | CN100506234C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease |
| 07/01/2009 | CN100506233C Radix actinidiae argutae extract and its anticanceruse |
| 07/01/2009 | CN100506232C Composition for use in treatment of ocular hypertension and glaucoma |
| 07/01/2009 | CN100506231C Anti-inflammatory compositions and methods of use |
| 07/01/2009 | CN100506230C Vascular intimal hyperplasia inhibitor |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 07/01/2009 | CN100506228C Lansoprazole enteric coated tablet and preparing method thereof |
| 07/01/2009 | CN100506227C Dripping pills containing. (R)-3-[(S)-(5-oxyl-2-pyrrolidinyl) carbonyl] - thiazolidine-4-carboxyl, and its preparation. method |
| 07/01/2009 | CN100506226C Compound famotidine chewing tablet preparation method |
| 07/01/2009 | CN100506225C Pharmaceutical use, medicine composition and preparation process of angelica oil components |
| 07/01/2009 | CN100506224C Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 07/01/2009 | CN100506223C Comprehensive utilizing method for red sage root super critical extract remainder |
| 07/01/2009 | CN100506222C Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
| 07/01/2009 | CN100506221C Therapeutic agent for cancer |
| 07/01/2009 | CN100506220C Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline |
| 07/01/2009 | CN100506060C One-step process for preparing gum |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7554008 Having higher activity for omega-3 fatty acids than omega-6 fatty acids, of given sequences; increasing polyunsaturated fatty acid (PUFA) content; vectors; transgenic plants, animals |
| 06/30/2009 | US7553981 within the oligomeric lipid molecule, a cross-linkage of respectively two adjacent lipid monomers is effected strictly alternately in the tail-to-tail arrangement via their hydrophobic fatty acid radical directly or using an intradimeric spacer with a freely selectable molecule chain length |
| 06/30/2009 | US7553979 Heat Shock Protein 90 inhibitors; e.g. breast cancer, prostate cancer |
| 06/30/2009 | US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 06/30/2009 | US7553975 2-(((2-amino-1-oxo-3-mercapto-propyl)-amino)-methyl)-5-phenyl-thiazole-4-carbonyl-methionine; useful for treating restenosis or tissue proliferative diseases |
| 06/30/2009 | US7553974 Dipotassium salt of (2R,4R)-monatin; superior in sweetness, preservation stability, solubility, and color stability superior to those of the monopotassium salt crystal |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553967 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553962 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/30/2009 | US7553950 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553876 angiogenesis inhibitors; a salicylamides; amphiphilic compounds; used with various antiinflammatory and cytotoxic agents as well as with radio-therapeutic agents to treat tumor growth and metastasis |
| 06/30/2009 | US7553875 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; (16-(3-chlorophenoxy)-17,18,19,20-tetranor PGF2 alpha ) cyclopropyl amide |
| 06/30/2009 | US7553874 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 06/30/2009 | US7553873 N1-benzyl-N2-[(4'-ethynyl-1,1'-biphenyl-4-yl)carbonyl]-L- alpha -glutamine; protease inhibitors; metalloenzyme inhibitors; anticarcinogenic agents; asthma; chronic obstructive pulmonary disease; atherocslerosis; aound healing agents; angiogenesis inhibitors; liver disorders; vision defects; shock |
| 06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
| 06/30/2009 | US7553871 Mixture in solvent such as ethylene glycol, propylene glycol, isopropanol; killing microorganisms on udder of milk producing animal |
| 06/30/2009 | US7553870 Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events |
| 06/30/2009 | US7553869 providing a dye 2-[(E)-2-(8-Dihexylamino-2-hydroxy-4,5-dioxo-4H,5H-pyrano[3,2-c]chromen-3-yl)-vinyl]-3,3-dimethyl-5-sulfo-1-(3-sulfo-propyl)-3H-indolium sodium salt or it's chelate compound and a biocompatible excipient to stain the protein by forming protein-dye complex |
| 06/30/2009 | US7553868 2-[(Aminocarbonyl)amino]-5-[2-{2-[{N-(2-chlorobenzyl)-N-methyl}amino]ethoxy}phenyl]-thiophene-3-carboxamide; serine/threonine kinase inhibitors; antiinflammatory agents; asthma; rheumatic diseases; antiarthritic agents; multiple sclerosis; chronic obstructive pulmonary disease |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553866 3-(2-Oxo-tetrahydrothiopyran-3-yl)propionic acid; inhibiting the prostrate specific antigen;angiogenesis inhibition; compulsive disorder, neuropathy, analgesics, anticarcinogenic agents; Huntinton's disease; antidiabetic agents; retinopathy; gluacoma; effecting transforming growth factor, glutamate |
| 06/30/2009 | US7553865 Compounded with glyceryl monostearate, sorbitan monostearate, or stearyl alcohol; excellent use feeling and excellent absorbability, causes no phase separation into an oil layer and an aqueous layer, stability |
| 06/30/2009 | US7553864 TACE inhibitors; rheumatoid arthritis, osteoarthritis, periodontitis, gingivitis, corneal ulceration, neovascular glaucoma, inflammatory bowel disease, multiple sclerosis and psoriasis |
| 06/30/2009 | US7553863 solution containing 4-methyl pyrazole containing less than 0.1% pyrazole, less than 10 ppm each of hydrazine and nitrobenzaldehyde; reacting propionaldehyde with triethyl orthoformate; reacting final intermediate with hydrazine to produce to produce 4-methylpyrazole; antidote for ethylene glycol posion |
| 06/30/2009 | US7553862 (Rac)-4-benzylamino-1-(3,4-dichloro-phenyl)-5-p-tolyl-1,5-dihydro-imidazol-2-one; glycine transport inhibitors; schizophrenia; Alzheimers' disease; dementia |
| 06/30/2009 | US7553861 Type-2 diabetes |
| 06/30/2009 | US7553860 e.g.(S)-methyl 5-(((3-(4-(1-hydroxyhexyl)phenyl)-2-oxooxazolidin-4-yl)methoxy)methyl)thiophene-2-carboxylate; prostaglandin EP2 agonist; ocular hypotensive, antiinflammatory agent; glaucoma, inflammatory bowel disease and as presurgical adjuncts |
| 06/30/2009 | US7553859 Macrocycles for the treatment of cancer |
| 06/30/2009 | US7553858 Synergistic centrally acting analgesics with improved efficiency and reduced side effects |
| 06/30/2009 | US7553857 S-omeprazole magnesium |
| 06/30/2009 | US7553856 Crystalline form of omeprazole |
| 06/30/2009 | US7553855 Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 06/30/2009 | US7553854 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 06/30/2009 | US7553853 crystalline or amorphous form of R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropane acetic acid and/or sodium salt, used for the treatment of asthma |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553851 2-(1-Azabicyclo[2.2.2]oct-3-yl)-N-(7-bromo-1-benzothien-2-yl)acetamide hydrochloride; nicotinic receptor agonists; cognition activators; learning enhancement; nootropic agents; demetia; cholinergic agents; Alzheimer's disease; brain traumas; stroke; attention deficit disorder; schizophrenia |
| 06/30/2009 | US7553850 Tricyclic-bridged piperidinylidene derivatives as δ-opioid modulators |
| 06/30/2009 | US7553849 Compounds |
| 06/30/2009 | US7553848 Vanilloid receptor ligands and their use in treatments |
| 06/30/2009 | US7553847 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder; 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 06/30/2009 | US7553846 2-alkylbenzoxazole carboxamides as 5-HT3 modulators |
| 06/30/2009 | US7553845 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 06/30/2009 | US7553844 Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors |
| 06/30/2009 | US7553843 Process for the preparation of purified crystalline CCI-779 |
| 06/30/2009 | US7553842 Topically active FK520 and FK506 analogs; calcineurin inhibitorse useful in the treatment of immunoregulatory and respiratory disorders; lung or heart transplantation; antiinflammatory agents; bronchitis; asthma; immunosuppressants; autoimmune diseases eosinophil-related diseases |
| 06/30/2009 | US7553841 Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/30/2009 | US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 06/30/2009 | US7553839 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/30/2009 | US7553838 Mitotic kinesin inhibitors |
| 06/30/2009 | US7553837 Phenylazole compounds production process and antioxidants |
| 06/30/2009 | US7553836 7-(4-Chlorophenyl)-2-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one trifluoroacetic acid salt; obesity; antidiabetic agents; antidepressants; anxiolytic agents; combination with antipsychotic drugs enhanced therayp for schizophrenic disorders |
| 06/30/2009 | US7553835 foam or mousse; antifungal such as ketoconazole, lower alcohol, fatty alcohol, a quaternary or ethoxylated sorbitan surfactant, water, hydrocarbon gas propellant; jock itch, tinea, dandruff and sebborheic dermatitis |
| 06/30/2009 | US7553834 Determining the appropriate medication where the patient answers a number of questions with scaled responses concerning the degree to which his mental state is affected by one or impaired modulation and/or activation; computer scoring determines dosage and medication; monitoring; maintaining ahistory |
| 06/30/2009 | US7553833 3,3-spiroindolinone derivatives |
| 06/30/2009 | US7553832 Tuberculosis; inhibition of protein autosplicing of intein-containing proteins; using various drugs, for example 2-methyl-4-((4-methyl-1,3,4-thiadiazol-2-yl)thio)quinoline or 1,2,3-trimethylsulfonyl-5-trifluoromethylbenzene |
| 06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
| 06/30/2009 | US7553830 Compositions for the delivery of negatively charged molecules |